Panda International

Panda International Monthly Round-up – March 2025! Funding and Partnerships 🤝 Hypera Pharma: Announced plans to launch a generic version of #Ozempic (#semaglutide) in Europe by 2026, targeting the growing diabetes and obesity treatment market. Roche and Zealand Pharma: Entered a €4.9 billion collaboration to develop #petrelintide, a long-acting amylin analogue for obesity treatment. Ionis Pharmaceuticals, Inc. and ONO PHARMACEUTICAL CO., LTD.: Partnered on #sapablursen, an RNA-targeted therapy for polycythemia vera, in a deal worth €860 million. Regulatory Developments 📃 EU Joint Clinical Assessment Regulation: Set to harmonise drug evaluations across member states in 2025, streamlining access for innovative therapies. Inflation Reduction Act (IRA): Impacting global pricing strategies, with European companies adapting to new Medicare price negotiations in the US. Drug Development Milestones 💊 AstraZeneca: Progressing with its next-generation antibody-drug conjugates (ADCs), targeting oncology and rare diseases. Novo Nordisk: Expanding trials for GLP-1 drugs to address conditions like sleep apnoea and non-alcoholic fatty liver disease. AI adoption in drug discovery is expected to drive 30% of new drug developments by 2025. Companies like Exscientia are leading the charge with AI-designed molecules entering clinical trials. Market Trends 📈 Increasing focus on biosimilars as patent cliffs loom, with companies like Sandoz and Biocon strengthening their portfolios. Rising interest in radiopharmaceuticals and cell and gene therapies (CGTs), particularly for rare diseases. Continued M&A momentum in Europe following GSK’s acquisition of IDRx, with immunology and neurology being key focus areas for deal-making. Analysts predict robust activity in oncology, driven by competition in the GLP-1 market. #PharmaTrends #DrugDevelopment #Biosimilars #PersonalisedMedicine

AI is revolutionising the fight against metabolic dysfunction-associated steatohepatitis (MASH), a chronic liver condition impacting millions worldwide. Read our latest blog to learn about the groundbreaking collaboration between Insilico Medicine and Therasid Bioscience. AI’s ability to rapidly identify and optimise drug candidates is transforming the healthcare landscape, setting new standards for speed and precision in pharmaceutical research. Read the full story here: https://lnkd.in/girR-ErT #AIinHealthcare #DrugDiscovery #BiotechInnovation #MASH #ArtificialIntelligence

Biomedical recruitment strategies for successful interviews.. The European biopharma market is projected to reach €112.92 billion by 2032. To keep up, organisations must adapt their recruitment strategies. Our latest blog post highlights effective approaches for biomedical recruitment: • Structured interviews ensure fair comparisons and reduce bias. • AI-powered screening and virtual reality simulations enhance candidate assessment. • Diverse hiring committees help mitigate biases during the hiring process. • Data-driven decision-making guides hiring choices. • Personalised communication improves the candidate experience. To navigate these challenges, our specialists are here to help. Contact Panda International today. #BiomedicalRecruitment #LifeSciences #TalentAcquisition #FutureOfHealthcare Read the full blog here: https://lnkd.in/gJJ7VyNc

Looking to build a team or advance your career in the life sciences? Check out our new resources and guides! We've compiled expert insights on hiring, career growth, and the latest trends shaping the Life Science industry. Access valuable content, including: ➡️ Expert guides on attracting and retaining top biotech talent ➡️ Insight reports on key challenges and opportunities in the life sciences ➡️ Strategies for success in the life science market Start exploring now: https://lnkd.in/gERFEG4A. #LifeSciences #Biotech #Hiring #CareerGrowth #TalentAcquisition #IndustryInsights

Are you struggling to find top Quality Assurance and Regulatory Affairs talent in the MedTech industry? Aimee Brenner, Partner & Principal Key Account Manager at Panda International, has created a comprehensive guide to help you navigate the complexities of cross-border recruitment. With over four years of experience connecting top talent with leading companies across Europe, Aimee understands the challenges and opportunities. This report is packed with insights, strategies, and expert perspectives to help you build a world-class MedTech team. Read our report on Navigating the Future of MedTech: Cross-Border Recruitment Insights here: https://lnkd.in/gYSfxPfe #MedTech #Recruitment #QualityAssurance #RegulatoryAffairs #Europe #TalentAcquisition #ExpertInsights #PandaInternational

What does it take to thrive in Life Sciences recruitment and build a high-performing team? In today’s edition of Panda Perspectives, we sit down with Judit Mateu, our Talent Acquisition Lead, as she shares her journey at Panda, what makes Life Sciences recruitment unique, and why recruiters looking for their next step should join us on this exciting journey. 👉 Read the latest edition of Panda Perspectives here: https://lnkd.in/eWJnnbjJ

Women in Biotech 2025 brought together over 250 life sciences leaders to celebrate innovation, inclusion, and the power of women shaping the future of biotech. Below are some of the key takeaways from the event ⬇️ Women in Biotech 2025 was more than an event - it was a movement to inspire, connect, and empower women shaping the future of life sciences. #womeninbiotech #IWD2025 #womeninlifescience #bigwib2025

At Panda, we’re committed to taking tangible steps towards gender equality, empowering women to succeed in every role across our business. As another International Women's Day comes around, we are grateful for all the work our female workforce is doing for our company, candidates, and clients! Some key stats from Panda: • 62% of our team are women • 56% of our senior leadership team are women Today, we celebrate the achievements of the women in our team, our industry, and beyond. Let’s continue pushing for equality, opportunity, and progress!

International Women's Day is just around the corner - a day dedicated to honouring the achievements of women and advocating for gender equality. This year's theme, "Accelerate Action," resonates deeply with our mission to empower and support talented professionals in the life sciences sector. At Panda International and Panda Intelligence, we believe in fostering an inclusive environment that supports the growth of all professionals, regardless of gender. Below, we've outlined several ways you can actively contribute to creating a more inclusive environment and support women in life sciences. #WomenInScience #WomenInSTEM #WomenInMedicine #WomenLeadersSummitEu #C5conferences #InternationalWomensDay #IWD2025 #GenderEquality #WomenInLeadership #womeninbiotech Johnson & Johnson Roche Pfizer PFIZER INC. ISPE ISPE San Francisco | Bay Area Chapter Organon C5 Group Inc.

The biotech industry is set for significant growth in 2025, but leaders in the sector will face critical challenges. Denzel Gieling, our Vice President of Client Services here at Panda International, has been at the forefront of helping life sciences executives navigate these complexities. Key Trends and Challenges: • Innovative Clinical Trials: The industry is embracing master protocols, real-world data, and adaptive designs to streamline drug development. • Collaborative Models: Partnerships and public-private collaborations are crucial for overcoming regulatory and financial hurdles. • Technological Advancements: AI and digital tools are optimizing trial efficiency and patient engagement. In this comprehensive report, Denzel Gieling offers detailed insights into how biotech companies can overcome future challenges. He explores strategies such as harnessing AI for drug discovery and implementing collaborative models to drive sustainable growth, providing industry leaders with actionable advice to inform their decision-making. Read the Full Report Here: https://lnkd.in/gMUpCXYh] #biotech #biotechnology #innovation #collaboration #clinicaltrials #drugdevelopment